Singapore
The Founder and Head of The Observational and Pragmatic Research Institute (OPRI) Singapore, an independent, research-driven organisation established to cultivate initiatives, provide evidence, and drive quality standards within the growing field of real-life, pragmatic, and observational research. This dynamic organisation delivers pragmatic clinical trials and real-life database research across multiple geographies, including territories in the United States, Europe, and the Asia-Pacific region, such as Singapore, South Korea, Taiwan, The Philippines, New Zealand, Australia, Japan, and China. http://opri.sg
The Head of Optimum Patient Care (OPC) Global, Australia and UK, a social enterprise which focuses on disease registries and quality improvement in primary and secondary care led by internationally recognised experts in all areas of respiratory medicine. Professor Price established the Optimum Patient Care Research Database (OPCRD), one of the largest enhanced healthcare databases holding anonymous data from over 1000 general practices and approximately 18 million patients in the UK. https://opcrd.co.uk/ He currently leads the first International Severe Asthma Registry (ISAR) by creating a consortium of world leaders at the forefront of severe asthma research from over 30 countries. His efforts have unified the severe asthma world by creating a vibrant space to exchange ideas and by standardising the data fields across countries, which is enabling data to be pooled and shared. https://isaregistries.org/ He leads the COllaboratioN on QUality improvement initiative for achieving Excellence in Standards of COPD care (CONQUEST), a novel, collaborative, interventional COPD registry. It comprises an integrated quality improvement program focusing on patients (diagnosed and undiagnosed) at a modifiable and higher risk of COPD exacerbations. CONQUEST is underpinned by 4-evidence based Quality Standards developed by 11 experts internationally recognized in their field and drives long-term, targeted, patient-centred changes in COPD management. The promotion of expert and guideline-led care aims to reduce exacerbation frequency and improve health care outcomes. https://conquest.care/